Beyond CAR T Cells: Other Cell-Based Immunotherapeutic Strategies Against Cancer

Background: Chimeric antigen receptor (CAR)-modified T cells have successfully harnessed T cell immunity against malignancies, but they are by no means the only cell therapies in development for cancer.Main Text Summary: Systemic immunity is thought to play a key role in combatting neoplastic diseas...

Full description

Bibliographic Details
Main Authors: Shabnum Patel, Rachel A. Burga, Allison B. Powell, Elizabeth A. Chorvinsky, Nia Hoq, Sarah E. McCormack, Stacey N. Van Pelt, Patrick J. Hanley, Conrad Russell Y. Cruz
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-04-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2019.00196/full